Differential pathological dynamics triggered by distinct Parkinson patient–derived α-synuclein extracts in nonhuman primates
Science Advances · 20.06.2025 · 11 (25)
DOI: 10.1126/sciadv.adu6050 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 20.06.2025. Verfasst von R Kinet und 23 weiteren Autor:innen. Beteiligte Einrichtung: Univ. Bordeaux, CNRS, IMN, UMR 5293, F-33000 Bordeaux, France. Hauptthemen laut MEDLINE: alpha-Synuclein, Parkinson Disease. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The presence of α-synuclein (α-syn) aggregates, such as Lewy bodies in patients with Parkinson’s disease (PD), contributes to dopaminergic cell death. Injection of PD patient–derived α-syn in nonhuman primates has illustrated the exquisite vulnerability of primate dopaminergic neurons. Here, we aimed to elucidate the temporal and spatial pathological changes induced by two distinct α-syn pathogenic structures, having large or small sizes. To unravel the underlying molecular pathways, we conducted a proteomic analysis of the putamen and the entorhinal cortex, two brain regions carrying notable α-syn pathology. We demonstrate that distinct assemblies of α-syn aggregates drive unique pathogenic changes that ultimately result in a comparable extent of nigrostriatal degeneration at the level of nigral dopaminergic neuron cell bodies and striatal dopaminergic terminals. More broadly, our findings identify pathogenic trajectories associated with large or small α-syn aggregates, suggesting the existence of several possible concomitant pathogenic routes in PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Univ. Bordeaux, CNRS, IMN, UMR 5293, F-33000 Bordeaux, France.
- HM CINAC, HM Puerta del Sur, Fundación HM Hospitales and CIBERNED and CEU-San Pablo University, Madrid, Spain.
- Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Instituto Carlos III, Madrid, Spain.
- Univ. Grenoble Alpes, Synchrotron Radiation for Biomedicine (STROBE), Grenoble, France.
- Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.
- CIC NanoGUNE BRTA, Tolosa Hiribidea 76, 20018 Donostia-San Sebastián, Spain.
ORCID-Profile: R Kinet, M Bourdenx, S Dovero, M Darricau, M-L Arotcarena, G Porras, M-L Thiolat, I Trigo-Damas, S Bohic, E Doudnikoff, M Goikoetxea, S Claverol, C Tokarski, B Mollenhauer, M T Herrero, M Vila, J A Obeso, E Bezard, B Dehay
Zitieren
APA
Kinet, R., Bourdenx, M., Dovero, S., Darricau, M., Arotcarena, M. L., Camus, S., Porras, G., Thiolat, M. L., Trigo-Damas, I., Bohic, S., Morari, M., Doudnikoff, E., Goikoetxea, M., Claverol, S., Tokarski, C., Kruse, N., Mollenhauer, B., Estrada, C., Garcia-Carrillo, N., …, & Dehay, B. (2025). Differential pathological dynamics triggered by distinct Parkinson patient–derived α-synuclein extracts in nonhuman primates. Science Advances, 11(25). https://doi.org/10.1126/sciadv.adu6050
Vancouver
Kinet R, Bourdenx M, Dovero S, Darricau M, Arotcarena ML, Camus S, et al. Differential pathological dynamics triggered by distinct Parkinson patient–derived α-synuclein extracts in nonhuman primates. Science Advances. 2025;11(25). doi:10.1126/sciadv.adu6050
BibTeX
@article{Kinet2025,
author = {Kinet, R and Bourdenx, M and Dovero, S and Darricau, M and Arotcarena, M-L and Camus, S and Porras, G and Thiolat, M-L and Trigo-Damas, I and Bohic, S and Morari, M and Doudnikoff, E and Goikoetxea, M and Claverol, S and Tokarski, C and Kruse, N and Mollenhauer, B and Estrada, C and Garcia-Carrillo, N and Herrero, M T and Vila, M and Obeso, J A and Bezard, E and Dehay, B},
title = {Differential pathological dynamics triggered by distinct Parkinson patient–derived α-synuclein extracts in nonhuman primates},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {25},
doi = {10.1126/sciadv.adu6050}
}
EUVIMED